Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
What's behind PEPFAR's funding cut threats?

As it wraps up its latest funding round, the President's Emergency Plan for AIDS Relief is prepared to introduce unprecedented cuts to country programs in sub-Saharan Africa, designed to spur domestic policy changes and programmatic improvements. But observers warn that if enacted, the cuts could undermine advances those countries have made against the HIV epidemic, particularly among marginalized communities that struggle to access health services.

Published
12 June 2019
From
Devex
CytoDyn: Uncovering An Opportunity

CytoDyn is moving their PRO 140 product candidate closer towards an FDA approval in HIV.

Published
12 June 2019
From
Seeking Alpha
HIV project in South Africa reaches 90-90-90 target one year ahead of deadline

The project achieved results including 94 per cent of HIV positive people on treatment, and 95 per cent of those having no detectable HIV virus. These great results show that the 90-90-90 targets can be achieved by working with the community.

Published
12 June 2019
From
Médecins Sans Frontières
Trump’s bid to wipe out AIDS will take more than a pill

Eradicating the virus will need to look less like a science experiment and more like a broad social welfare program.

Published
11 June 2019
From
Politico
Which HIV Prevention Methods Are Most Cost Effective in Sub-Saharan Africa?

Researchers conducted a systematic review of 60 studies in search of answers.

Published
11 June 2019
From
POZ
Government is accused of 'not caring' about HIV after 'disgraceful' decision to deny people in England access to free self-testing kits

Public Health England last year offered firms the chance to sell their self-testing kits to the NHS, but later withdrew the offer completely. In a scathing attack on the move, the manufacturer of a type of testing kit branded it 'disgraceful', 'discriminatory' and 'small-minded'.

Published
10 June 2019
From
Daily Mail
Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.

Published
10 June 2019
From
Fred Hutchinson Cancer Research Center
UCSF loses contract as Trump administration restricts fetal tissue research

The Trump administration on Wednesday announced major new restrictions in funding of research involving human fetal tissue — a product that many scientists say is irreplaceable in studying certain diseases — in a move that immediately ended a decades-long partnership with UCSF involving HIV research.

Published
07 June 2019
From
San Francisco Chronicle
Global ingredient shortage caused ARV stockouts

A worldwide shortage of an active pharmaceutical ingredient is the reason behind the anti-retroviral (ARV) medication shortfall across the country, the department of health confirmed. The anti-retroviral drug called Lamivudine is currently in short supply globally and this has affected ARVs that contain this ingredient.

Published
07 June 2019
From
Health-e
Community based adherence clubs have higher drop-out rates than those based in clinics

Differentiated care models need further investigation to support people living with HIV with taking their antiretroviral treatment (ART).

Published
07 June 2019
From
Avert
← First12345...545Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.